Official: Merck to help produce rival J&J's COVID-19 vaccine
WASHINGTON (AP) — Drugmaker Merck & Co. will help produce rival Johnson & Johnson’s newly approved coronavirus vaccine in an effort to expand supply more quickly, a Biden administration official confirmed Tuesday.
The announcement comes as the White House looks to speed the production of the single-dose vaccine. Officials have said J&J faced unexpected production issues with its vaccine and produced only 3.9 million doses ahead of its receiving emergency use authorization on Saturday. The company says it is on pace to deliver 100 million doses by the end of June.
The assistance from Merck was expected to help J&J meet its production commitments and expand supply even further, but the administration did not immediately provide specifics.
President Joe Biden is set to highlight the development in a speech Tuesday afternoon. The official confirmed Merck’s involvement on condition of anonymity ahead of Biden’s public announcement.
The news was first reported by The Washington Post.
Desktop NewsClick to open Continuous News in a sidebar that updates in real-time.
Federal funds may push aside gas tax bills
Garret Graves among lawmakers to meet with Biden on infrastructure; 'top priority'...
Blood trail led police to alleged killer's room after stabbing at assisted...
A Denham Springs fundraiser hopes to raise money for a man severely...
A 67-year-old woman was stabbed to death Sunday by a man at...
Southeastern regains sole possession of first place in Southland standings with win...
Max Johnson in the mix for LSU starting quarterback job
Coach O admits to mistakes, takes steps to correct them in the...
Saints QB Jameis Winston gets emotional discussing Drew Brees
Southern football on the road to play Texas Southern